Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.98 USD | -5.01% | -3.40% | -29.56% |
May. 30 | Monte Rosa Therapeutics Names Three Insiders to Leadership Team | MT |
May. 30 | Monte Rosa Therapeutics, Inc. Announces Executive Promotions | CI |
Business Summary
Number of employees: 130
Managers
Managers | Title | Age | Since |
---|---|---|---|
Markus Warmuth
CEO | Chief Executive Officer | 53 | 19-12-31 |
Chief Operating Officer | - | 21-02-28 | |
Filip Janku
CTO | Chief Tech/Sci/R&D Officer | 50 | 21-05-31 |
Sharon Townson
CTO | Chief Tech/Sci/R&D Officer | 49 | 20-06-30 |
John Castle
CTO | Chief Tech/Sci/R&D Officer | 54 | 20-04-30 |
Philip Nickson
LAW | General Counsel | 45 | 21-02-28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew Schiff
CHM | Chairman | 58 | 20-08-31 |
Christine Siu
BRD | Director/Board Member | 47 | 20-11-30 |
Chandra Paul Leo
BRD | Director/Board Member | 53 | 20-08-31 |
Ali Behbahani
BRD | Director/Board Member | 45 | 20-03-31 |
Anthony Manning
BRD | Director/Board Member | 62 | 23-07-24 |
Markus Warmuth
CEO | Chief Executive Officer | 53 | 19-12-31 |
Jan Skvarka
BRD | Director/Board Member | 57 | 23-03-22 |
Director/Board Member | 55 | 20-05-31 | |
Alexander Mayweg
BRD | Director/Board Member | 49 | 18-03-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 60,848,785 | 60,405,481 ( 99.27 %) | 10,005 ( 0.0164 %) | 99.27 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.56% | 243M | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- GLUE Stock
- Company Monte Rosa Therapeutics, Inc.